Meeting
2014 ASCO Annual Meeting
Integrative whole-genome copy number analysis and mutation profiling of FFPE brain tumor specimens and potential in designing multi-arm clinical trials.
Authors
Shakti Ramkissoon
Dana-Farber Cancer Institute, Boston, MA
Shakti Ramkissoon , Wenya L. Bi , Sam Haidar , Jane B. Cryan , David A. Reardon , Eudocia Quant Lee , Mikael L. Rinne , Andrew David Norden , Lakshmi Nayak , Andrea Lyn Russo , Nils D. Arvold , Sandro Santagata , Ian F. Dunn , Rebecca D. Folkerth , Neal Ian Lindeman , Rameen Beroukhim , Azra Ligon , Patrick Y. Wen , Brian Michael Alexander , Keith L. Ligon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 11098)
DOI
10.1200/jco.2014.32.15_suppl.11098
Abstract #
11098
Poster Bd #
380
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Combined whole genome copy number genotyping and multiplex somatic mutation profiling of FFPE brain tumor specimens for clinical diagnosis and trial selection.
First Author: Brian Michael Alexander
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib
Poster
2022 ASCO Annual Meeting
Next-generation sequencing (NGS) for identifying actionable molecular alterations in patients with newly diagnosed and recurrent IDHwt-glioblastoma (GBM): A large mono-institutional experience.
First Author: Marta Padovan
Poster
2018 ASCO Annual Meeting
Real-time circulating tumor DNA profiling of advanced cholangiocarcinoma (CCA).
First Author: Kabir Mody